Previous mistakes investors cannot afford to repeat in 2026

2026 is not a “new normal.” It’s a faster normal.

And the biggest risk right now isn’t that you pick the wrong deal. It’s that you keep using the same mental model that worked when the world moved slower.

Here are the mistakes I keep seeing—smart people, serious funds, good operators—still making. And in 2026, these aren’t harmless. They’re expensive.

1) Believing last year’s moat still exists

Too many investors still underwrite differentiation as if product advantage decays slowly.

It doesn’t. In software-heavy markets, “unique” is becoming a short-lived condition. Features get copied, approximated, bundled, or automated away. Customers learn fast. Competitors ship fast. Platforms absorb fast. If your thesis depends on “they can’t replicate this,” you’d better be able to say why—and that “why” can’t be “because it took them years to build it.”

2) Treating AI disruption as a slide, not a holding-by-holding exposure map

Most portfolios have an “AI view.” Few have an AI exposure view. That’s the difference between posture and control. You need to know, company by company:

• where revenue depends on humans doing repeatable work

• where pricing depends on complexity that AI is stripping out

• where churn is masked by contract cycles

• where customers can self-serve what your company sells

If you can’t point to the top five revenue lines most at risk and explain the mechanism, you’re guessing.

3) Trusting lagging indicators to warn you in time

Renewals lag. Reports lag. Management narratives lag. AI doesn’t. By the time churn shows up cleanly, the market has already moved. You’ll hear “a couple of clients delayed decisions,” “longer procurement,” “budget tightening.” Meanwhile the underlying truth is simple: the buyer’s baseline just changed. In 2026, early signals matter more than quarterly comfort. Discounting patterns. Support load shifts. Sales cycle changes. Feature usage drop-off. Customer success “firefighting.” These are your smoke alarms.

4) Confusing cost collapse with safety

Lower build costs feel like reduced risk. Sometimes it’s the opposite. If it’s cheap for you to build, it’s cheap for competitors too. A world where capability is cheap doesn’t automatically reward the builder. It rewards the one with distribution, trust, data access, and speed of iteration. If your investment case is “they can build faster now,” ask the next question: so can everyone else—why do they still win?

5) Missing the other side of the same curve

Here’s the twist most people still don’t internalise: The same curve that commoditises parts of B2B software and services is also making Europe’s deeptech assets—robotics, sensors, materials, energy, defence-adjacent systems—faster to validate and cheaper to de-risk. 2026 Same Curve Two Sides brief…That means two things can be true at once:

• some “safe” recurring revenues are more fragile than they look

• some slow-moving R&D assets are closer to commercial reality than investors assume

If you only look for disruption risk, you miss the opportunity side. If you only chase the shiny AI deals, you miss the quiet leverage sitting inside Europe’s funded innovation base.

6) Letting the institutional clock dictate the capability clock

This is the killer mistake, especially in Europe. The funding clock, the budgeting clock, the governance clock—these are built for stability. AI is built for acceleration.

If your investment or portfolio operating model can’t re-assess assumptions quarterly—capability, cost, speed, competition—you will keep paying for plans that were correct when they were written and wrong when they’re executed.

7) Waiting for “perfect information” instead of running probes

In 2026, the winning behaviour is not certainty. It’s controlled testing. Small, reversible probes beat big, heroic bets.

• fast customer tests that reveal self-serve risk

• pricing experiments that show willingness-to-pay under AI pressure

• operational pilots that expose where margin can be protected or where it leaks

• targeted scans of publicly funded pipelines that surface undervalued assets

If you can’t run a probe in weeks, you’re not learning fast enough.

What I’d do instead: a Two-Sided Curve Scan

If you want something practical—no theatre—run this:

1. Rank holdings by AI vulnerability (margin exposure + self-serve risk + feature commoditisation).

2. Map contract reality (renewal dates, hidden churn risk, discounting, support signals).

3. Track capability shifts quarterly (what changed that breaks your assumptions).

4. Build a deeptech sourcing lane from Horizon Europe and adjacent programmes—focused on assets where AI compresses validation and time-to-market. 2026 Same Curve Two Sides brief…

5. Match opportunity to exposure (where deeptech can create new product lines, defensibility, or efficiency inside your portfolio).

6. Run short pilots and make clean kill/scale decisions.

Same curve. Two sides. 2026 punishes investors who only see one. If you want to pressure-test a portfolio—or build a real sourcing lane from Europe’s innovation base into investable outcomes—that’s exactly the kind of work I do through Gaoithe Advisory.